Average Co-Inventor Count = 6.88
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vertex Pharmaceuticals, Inc. (10 from 1,149 patents)
2. Chroma Therapeutics Limited (6 from 19 patents)
3. Glaxosmithkline Intellectual Property Development Limited (1 from 230 patents)
17 patents:
1. 9321718 - Benzamide derivatives and their use as HSP90 inhibtors
2. 9133104 - Enzyme inhibitors
3. 8962825 - Hydroxamates as inhibitors of histone deacetylase
4. 8686032 - Enzyme inhibitors
5. 8524720 - Substituted N-(pyrazol-5-yl)-pyrrolo[3,2-D]pyrimidin-4-amine useful as protein kinase inhibitors
6. 7973181 - Hydroxamic acid derivatives as inhibitors of HDAC enzymatic activity
7. 7939666 - Enzyme inhibitors
8. 7932246 - Histone deacetylase inhibitors
9. 7855214 - Fused cyclic systems useful as inhibitors of TEC family protein kinases
10. 7691853 - Pyrazole compounds useful as protein kinase inhibitors
11. 7098330 - Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors
12. 7041687 - Indazole compounds useful as protein kinase inhibitors
13. 7008948 - Fused pyrimidyl pyrazole compounds useful as protein kinase inhibitors
14. 6989385 - Pyrazole compounds useful as protein kinase inhibitors
15. 6660731 - Pyrazole compounds useful as protein kinase inhibitors